Markers of Prognosis and Response to Therapy in Patients With Metastatic Brain Tumors Undergoing Stereotactic Radiosurgery (SRS)



Status:Recruiting
Conditions:Brain Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:19 - 80
Updated:4/2/2016
Start Date:January 2013
Contact:Tracie Granger
Email:tracie.granger@swedish.org
Phone:206-215-2466

Use our guide to learn which trials are right for you!

This registry study will evaluate patients with metastatic brain tumors undergoing, or
having undergone, stereotactic radiosurgery (SRS) at Swedish Medical Center. Clinical
outcomes will be evaluated at the 3, 6 and 12-month time points. Clinical data, SRS
treatment data, and imaging data (including anatomic and advanced imaging sequences obtained
prior to and serially following SRS) will be archived in an online informatics platform,
specifically a metastatic brain tumor registry known as the Comprehensive Neuro-oncology
Data Repository for Metastatic Tumors (CONDR - Mets).


Inclusion Criteria:

- Adult patients (>18 yo) with a pathological diagnosis of metastatic brain cancer

- Participants must have >4 tumors felt to require stereotactic radiosurgery

- Karnofsky scale of > 70 at the time of initial treatment

- Age < 80

Exclusion Criteria:

- Karnofsky scale <70

- Age > 80

- Inability to undergo MR imaging studies
We found this trial at
1
site
5300 Tallman Ave NW
Seattle, Washington 98122
(206) 782-2700
Swedish Medical Center Since 1910, Swedish has been the region's hallmark for excellence in health...
?
mi
from
Seattle, WA
Click here to add this to my saved trials